February 15, 2026 / Last updated : February 15, 2026 Michele Webb artificial intelligence What It Means When a Cancer Registrar Says, “There Is No Room for AI in the Cancer Registry” Why do cancer registrars say, “There is no room for AI in the cancer registry?” As a cancer registrar who advocates for thoughtful AI automation, I hear this phrase often. In most cases, it is not opposition to innovation. It is a signal of perceived risk without control. AI has been part of registry work […]
November 18, 2025 / Last updated : January 8, 2026 Michele Webb case finding automation Closing Casefinding Gaps in Leukemia, Lymphoma and Multiple Myeloma Automation sees what routine workflows miss. Real-time data turns “negative” into knowledge. The American Cancer Society projects 2,041,910 new cancer diagnoses in 2025, with hematologic malignancies accounting for 9.5% of all leukemia, lymphoma, and multiple myeloma cases. Roughly two-thirds of these patients will undergo a bone marrow aspirate biopsy as part of staging or diagnosis. Yet, […]
November 18, 2025 / Last updated : January 8, 2026 Michele Webb case finding automation Symptoms Tell a Story Myelofibrosis begins quietly. Your case finding practice makes a difference. Primary myelofibrosis often begins quietly — fatigue, anemia, maybe a larger spleen — until it becomes a diagnosis hidden in plain sight. For Oncology Data Specialists, catching those early signals in the record can mean the difference between “missed” and “found.” Spotlight on Myelofibrosis – […]
October 21, 2025 / Last updated : January 11, 2026 Michele Webb case finding automation Close the Gap: Hematology Clinical data tells the story pathology cannot. Roughly 8–12% of hematologic malignancies are clinically diagnosed rather than pathologically confirmed (Deppen et al., 2020; CDC USCS, 2025). Without deliberate data curation, they may never be reviewed or abstracted by the cancer registry. When medical disease indices (MDI) are pre-filtered and do not include all ICD-10 codes, […]